A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators

This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shanlian, Zhang, Yabing, He, Jiangjiang, Du, Lixia, Xu, Mingfei, Xie, Chunyan, Peng, Ying, Wang, Linan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519586/
https://www.ncbi.nlm.nih.gov/pubmed/26091710
http://dx.doi.org/10.1007/s40258-014-0150-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519586/
https://www.ncbi.nlm.nih.gov/pubmed/26091710
http://dx.doi.org/10.1007/s40258-014-0150-5

Ejemplares similares